Acute Kidney Injury Definition and Diagnosis

Diagnostic Criteria

• The Kidney Disease Improving Global Outcomes (KDIGO) criteria define Acute Kidney Injury (AKI) as an abrupt decrease in kidney function occurring over 7 days or less, characterized by either a rise in serum creatinine of >26 μmol/L (0.3 mg/dL) within 48 hours, or a 50% or greater increase in serum creatinine from baseline within 7 days, or a reduction in urine output to less than 0.5 mL/kg/h for 6 hours or more 1, 2
• The American College of Physicians and other medical societies adopt the KDIGO criteria for AKI diagnosis, which includes three stages based on serum creatinine and urine output criteria 1

Clinical Significance

• Small increases in serum creatinine (>0.3 mg/dL) are independently associated with approximately fourfold increase in hospital mortality, according to the Kidney Disease Improving Global Outcomes (KDIGO) guidelines 1
• AKI is part of a continuum that can lead to acute kidney disease (AKD) and chronic kidney disease (CKD), as stated by the National Kidney Foundation and the American Society of Nephrology 3

AKI Staging

• The KDIGO guidelines stage AKI based on serum creatinine and urine output criteria, with Stage 1 being a rise of >26 μmol/L (0.3 mg/dL) within 48 hours or 50-99% increase from baseline within 7 days, and Stage 3 being a ≥200% increase from baseline within 7 days or serum creatinine ≥354 μmol/L with either rise of >26 μmol/L within 48 hours or >50% increase from baseline within 7 days 1

Clinical Implications

• Early identification of AKI using standardized criteria allows for prompt intervention and potentially improved outcomes, as recommended by the Kidney Disease Improving Global Outcomes (KDIGO) guidelines 2
• The staging system correlates with mortality risk and other clinical outcomes, according to the American College of Cardiology and the American Heart Association 1

Common Pitfalls in AKI Diagnosis

• Relying solely on serum creatinine without considering urine output criteria may miss cases of AKI, as warned by the Kidney Disease Improving Global Outcomes (KDIGO) guidelines 2
• Failure to establish an accurate baseline creatinine can lead to misclassification, as noted by the National Kidney Foundation and the American Society of Nephrology 1

Acute Kidney Injury Definition and Diagnosis

Introduction to AKI

• The Kidney Disease Improving Global Outcomes (KDIGO) defines Acute Kidney Injury (AKI) as an abrupt decrease in kidney function, but specific criteria are provided in the context of AKD and AKI relationship 4

AKI in Relation to Acute Kidney Disease (AKD)

• AKI is a subset of Acute Kidney Disease (AKD), which is defined as kidney abnormalities or decreased GFR for less than 3 months, as described by the Kidney International guideline 4
• AKD can occur with or without AKI, consistent with the 2012 AKI guideline, and represents the course of disease after AKI among patients in whom renal pathophysiologic processes are ongoing 4
• The term "acute kidney disease and disorders" (AKD) describes abnormalities of kidney function and/or structure with implications for health that persist beyond AKI, according to Nature Reviews Nephrology 5
• AKD represents the course of disease after AKI among patients in whom renal pathophysiologic processes are ongoing, as noted in Nature Reviews Nephrology 5

Common Pitfalls in AKI Diagnosis

• Not recognizing that AKI can occur in both hospital and community settings, with community-acquired AKI often going undetected, is a common pitfall, as stated in Kidney International 4

Acute Kidney Injury Definition and Clinical Significance

Introduction to AKI

• Even small increases in serum creatinine (≥0.3 mg/dL) are independently associated with approximately a fourfold increase in hospital mortality, which is why this threshold was incorporated into the KDIGO criteria, as noted in research published in Gut in 2015 6

Limitations of AKI Criteria

• In certain populations, particularly patients with cirrhosis and ascites, urine output criteria are unreliable because these patients are frequently oliguric with avid sodium retention yet may maintain relatively normal glomerular filtration rate, as discussed in Gut in 2015 6
• Serum creatinine has inherent limitations as a marker of kidney function, being affected by factors such as decreased creatinine formation from muscle in patients with muscle wasting, increased tubular secretion of creatinine, volume expansion diluting serum creatinine, and interference with creatinine assays by elevated bilirubin, as noted in Gut in 2015 6

Acute Kidney Injury Definition and Staging

Introduction to AKI

• The Kidney Disease: Improving Global Outcomes (KDIGO) guideline defines Acute Kidney Disease (AKD) as acute or subacute kidney damage and/or loss of function for a duration between 7 and 90 days after exposure to an AKI initiating event, with AKD that persists beyond 90 days considered chronic kidney disease 7

Diagnostic Considerations

• Using known creatinine values is superior to imputation methods when establishing baseline, as back-calculation from an estimated GFR of 75 mL/min/1.73 m² may overestimate AKI incidence in populations with high CKD prevalence 7

Relationship Between AKI and AKD

• AKI represents the acute phase (≤7 days), while AKD captures the subacute recovery or progression phase, existing within a broader continuum of kidney injury 7

Acute Kidney Injury and Disease Definitions and Implications

Introduction to AKI and AKD

• The Kidney International guideline defines AKI as an abrupt decrease in kidney function occurring over 7 days or less, while AKD is a broader term that encompasses AKI plus any kidney dysfunction or damage lasting between 7 and 90 days, with AKI being a subset of AKD 8, 9
• The Kidney International guideline suggests that AKD captures the subacute phase (7-90 days) and includes all patients meeting AKI criteria PLUS those with kidney abnormalities not severe enough to meet AKI thresholds 8, 9

Temporal Definitions and Clinical Significance

• The Kidney International guideline focuses specifically on functional criteria (creatinine and urine output) without incorporating structural damage markers for AKI 10
• The Kidney International guideline defines AKD as acute or subacute kidney damage and/or loss of function for 7-90 days after an AKI initiating event, which can occur with OR without preceding AKI 8, 9
• AKD not associated with AKI is nearly 3 times more prevalent than AKI itself, according to the Kidney International guideline 11
• Patients with AKD without AKI have an adjusted hazard ratio of 2.26 for the composite outcome of incident CKD, kidney failure, or death, as reported by the Kidney International guideline 8, 9

Clinical Implications and Outcomes

• The Nature Reviews Nephrology guideline suggests that a patient whose creatinine rises slowly over 2 weeks (not meeting the 48-hour or 7-day AKI criteria) still has AKD and requires intervention 12, 10
• The Kidney International guideline states that community-acquired AKD often goes undetected because it doesn't meet dramatic AKI criteria, yet has long-term health implications 8, 9
• The AKD framework allows clinicians to capture and manage patients in the recovery or progression phase after AKI who still have ongoing kidney dysfunction, according to the Nature Reviews Nephrology guideline 12

Disease Progression and Management

• The Kidney International guideline notes that patients can have structural kidney damage (abnormal urinalysis, proteinuria, imaging findings) without meeting functional AKI criteria—this is still AKD 10
• The Nature Reviews Nephrology guideline states that the term AKD was specifically created to fill the gap between AKI and CKD definitions 12
• The Kidney International guideline defines the timeline for AKI, AKD, and CKD as follows: 0-7 days = AKI, 7-90 days = AKD, and >90 days = CKD 12

Acute Kidney Injury Diagnosis and Criteria

Diagnostic Criteria and Limitations

• The European Association for the Study of the Liver and other societies suggest that urine output criteria are unreliable in patients with cirrhosis and ascites, who are frequently oliguric with avid sodium retention yet may maintain relatively normal GFR 13
• The same societies also note that urine collection is often inaccurate in clinical practice, influenced by body weight, race, age, gender, and diuretic use 13

KDIGO Guidance on Acute Kidney Injury Superimposed on Chronic Kidney Disease (AKI on CKD)

Definition & Diagnostic Criteria

• AKI on CKD is defined as an acute decline in kidney function that meets KDIGO AKI criteria (serum creatinine increase ≥ 0.3 mg/dL within 48 h or ≥ 50 % rise from baseline within 7 days or urine output < 0.5 mL/kg/h for ≥ 6 h) occurring in a patient whose baseline kidney function is already impaired (eGFR < 60 mL/min/1.73 m² or markers of kidney damage for > 3 months). 14, 15, 16

• The condition represents the superimposition of AKI on pre‑existing CKD, creating a particularly high‑risk clinical phenotype. 14

• Baseline CKD stage should be documented using the KDIGO CGA classification (Cause, GFR category G1‑G5, Albuminuria category A1‑A3). 15, 16

AKI Diagnosis Relative to CKD Baseline

• AKI on CKD is diagnosed when any of the KDIGO AKI thresholds are met relative to the patient’s established CKD baseline. 15, 16

• Staging of the AKI component follows the standard KDIGO AKI stages, applied to the magnitude of change from the CKD baseline.

Acute Kidney Disease (AKD) Framework

• When kidney dysfunction persists beyond 7 days but less than 90 days, the patient is classified as having AKD on CKD. 14

• AKD is defined by any of the following:

• AKI is a subset of AKD; AKD may occur with or without meeting formal AKI criteria. 14, 17

• If dysfunction persists > 90 days, the patient is described as CKD with a history of AKD, which confers an increased risk of further CKD progression. 14, 18

Consensus Statements (KDIGO)

• KDIGO endorses the same standardized AKI definitions for patients with or without pre‑existing CKD. 14, 15, 16

• The 2021 KDIGO Consensus Conference explicitly addressed the continuum of AKI → AKD → CKD, harmonizing terminology across this spectrum. 14

• According to KDIGO:
  14, 15, 16

• KDIGO recognizes that AKI and CKD are interconnected syndromes; AKI occurring in CKD patients represents a high‑risk phenotype. 14, 19

Clinical Outcomes & Prognosis

• Patients with AKD on CKD have markedly higher mortality (47 % vs 19 % for CKD alone) and an odds ratio of 16.8 for incident CKD progression. 14

• Adjusted hazard ratio for mortality is 2.51 for patients who develop AKD after AKI compared with those who do not develop AKD. 14

• In cardiac‑surgery cohorts, AKD on CKD confers an odds ratio of 16.8 for progression to more advanced CKD stages versus CKD alone. 14

• Even after apparent recovery, long‑term risk of kidney failure remains substantially elevated. 14, 19

Evidence‑Based Strategies for Distinguishing AKI from CKD in First‑Time Presentations

Baseline Kidney Function Assessment

• Prior creatinine values are essential and superior to imputed baselines for distinguishing acute kidney injury (AKI) from chronic kidney disease (CKD) when a patient presents with abnormal renal function for the first time. 20
• An aggressive search of medical records for any creatinine measurements obtained in the preceding 3–12 months—including outpatient labs, emergency‑department visits, pre‑operative assessments, and prior hospital admissions—is the single most important step in establishing baseline kidney function. 20
• When no prior creatinine is available, back‑calculating an assumed eGFR of 75 mL/min/1.73 m² should be avoided because it overestimates AKI incidence in populations with a high prevalence of CKD. 20

Temporal Framework for Kidney Disease Classification

• Kidney dysfunction persisting 7–90 days after onset is classified as Acute Kidney Disease (AKD), encompassing persistent AKI or sub‑acute injury that does not meet strict AKI thresholds. 20
• Kidney dysfunction lasting > 90 days is defined as Chronic Kidney Disease (CKD), characterized by chronic kidney damage or an eGFR < 60 mL/min/1.73 m². 20
• If a patient is first evaluated after kidney dysfunction has persisted beyond 7 days, the condition should be labeled AKD and the clinician should investigate whether an antecedent AKI episode occurred. 20